Obesity and infertility

Reviews in Gynaecological Practice

Volumn 3, Issue 3, 2003, Pages 120-126

  Parihar, Mandakini ^a,b  

^a KJ Somaiya Medical College   (India)

^b Mandakini IVF Center   (India)

Author keywords

Infertility; Obesity; PCOS

Indexed keywords

CLOMIFENE; GONADOTROPIN ANTAGONIST; INSULIN; LEPTIN; METFORMIN; RECOMBINANT LEPTIN;

ANOVULATION; BODY FAT; BODY HEIGHT; BODY WEIGHT; CONGENITAL LEPTIN DEFICIENCY; DRUG MEGADOSE; FEMALE INFERTILITY; HIRSUTISM; HORMONE DEFICIENCY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENSTRUATION DISORDER; MOLECULAR CLONING; MULTIPLE PREGNANCY; OBESITY; OVARY POLYCYSTIC DISEASE; REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION; THERMOGENESIS; WEIGHT REDUCTION;

EID: 15744402271     PISSN: 14717697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-7697(03)00061-3     Document Type: Review

References (33)

1. Legato MJ. Gender-specific aspects of obesity. Int J Fertil Menopausal Stud 1997;42:184-97.
2. Norman RJ, Mahabeer S, Masters S. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril 1995;63:58-62.
3. Hollmann M, Runnebaum B, Gerhard I. Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women. Int J Obesity 1997;21:476-83.
4. Lazurova I, Dravecka I. Obesity and disorders of the menstrual cycle. Vnitr Lek 2002;48(4):349-52.
5. Bolumar F, Olsen J, Rebagliato M, Saez-Lloret I, Bisanti L. Body mass index and delayed conception: a European multicenter study on infertility and subfecundity. Am J Epidemiol 2000;151(11):1072-9.
6. Pankov YA. Adipose tissue as an endocrine organ regulating growth, puberty, and other physiological functions. Biochemistry 1999;64(6):601-9.
7. Butzow TL, Lehtovirta M, Siegberg R, et al. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women. Clin Endocruiol Metab 2000;85(9):3271-5.
8. Lindheim SR, Sauer MV, Carmina E, et al. Circulating leptin levels during ovulation induction: relation to adiposity and ovarian morphology. Fertil Steril 2000;73(3):493-8.
9. Fedorcsak P, Storeng R, et al. Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients. Scand J Clin Lab Invest 2000;60(8):649-55.
10. Salvador J, Gomez-Ambrosi J, Fruhbeck G. Perspectives in the therapeutic use of leptin. Expert Opin Pharmacother 2001;2(10):1615-22.
11. O'Brien PE, Dixon JB. The extent of the problem of obesity. Am J Surg 2002;184(6B):S4-8.
12. Norman RJ, Masters SC, Hague W, Beng C, Pannall P Wang JX. Metabolic approaches to the sub-classification of polycystic ovary syndrome. Fertil Steril 1995;63:329.35.
13. Moran LJ, Norman RJ. The obese patient with infertility: a practical approach to diagnosis and treatment. Nutr Clin Care 2002;5(6):290-7.
14. Mitchell GW, Rogers J. The influence of weight reduction on amenorrhea in obese women. NEJM 1953;249:835-7.
15. Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm AA. The association of obesity with infertility and related menstural abnormalities in women. Int J Obes 1979;3:57-73.
16. Lake JK, Power C, Cole TJ. Womens reproductive health: the role of body mass index in early and adult life. Int J Obesity 1997;21:432-8.
17. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-11.
18. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology 1994;5:247-50.
19. Cogswell ME, Perry GS, Schieve LA, Dietz WH. Obesity in women of childbearing age: risks, prevention, and treatment. Prim Care Update Ob Gyns 2001;8(3):89-105.
20. Diamanti-Kandarakis E, Bergiele A. The influence of obesity on hyperandrogenism and infertility in the female. Obes Rev 2001;2(4):231-8.
21. Wang X, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. Br Med J 2000;321:1320-1.
22. Homburg R, Insler V. Ovulation induction in perspective. Hum Reprod Update 2002;8(5):449-62.
23. Homburg R. Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism. Hum Reprod 2002;17(4):853-6.
24. Lewis CG, Warnes GM, Wang XJ, Matthews CD. Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women. Fertil Steril 1990;53:1097-9.
25. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995;10:2705-12.
26. Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000;79(1):43-8.
27. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002;10(6):551-4.
28. Winter E, Wang J, Davies MJ, Norman R. Early pregnancy loss following ART treatment. Hum Reprod 2002;17(12):3220-3.
29. Norman RJ. Obesity and infertility. In: Hansotia MD, Desai SK, Parihar MA, editors. Advanced infertility management. Jaypee Publications India Ltd., 2002.
30. Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol 2002;147(6):717-25.
31. Haas DA, Carr BR, Attia GR. Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2003;79(3):469-81.
32. Krizanovska K, Ulcova-Gallova Z, Bouse V, Rokyta Z. Obesity and reproductive disorders. Sb Lek 2002;103(4):517-26.
33. Kazerooni T, Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Gynecol Endocrinol 2003;17(1):51-6.